Covered recipient · General Payments record
SANDEEPKUMAR GUPTA
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$3,058.10
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $534.89 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $254.25 | 2 |
| Acerta Pharma LLC | $150.69 | 2 |
| Amgen Inc. | $39.63 | 2 |
| GlaxoSmithKline, LLC. | $38.50 | 2 |
| Janssen Biotech, Inc. | $34.24 | 1 |
| Actelion Pharmaceuticals US, Inc. | $17.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $17.58 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078897049 | CMS |
| Amgen Inc. | $16.06 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115688046 | CMS |
| Amgen Inc. | $23.57 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115688056 | CMS |
| AstraZeneca Pharmaceuticals LP | $129.94 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104537706 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.75 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105638814 | CMS |
| GlaxoSmithKline, LLC. | $19.48 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116634264 | CMS |
| GlaxoSmithKline, LLC. | $19.02 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115732274 | CMS |
| Janssen Biotech, Inc. | $34.24 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078827940 | CMS |
| PFIZER INC. | $133.18 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131744092 | CMS |
| PFIZER INC. | $121.07 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131871667 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.